Literature DB >> 16694672

LACTIC ACID PRODUCTION DURING REST AND AFTER EXERCISE IN SUBJECTS WITH VARIOUS TYPES OF HEART DISEASE WITH SPECIAL REFERENCE TO CONGENITAL HEART DISEASE.

P Hallock1.   

Abstract

Entities:  

Year:  1939        PMID: 16694672      PMCID: PMC434885          DOI: 10.1172/JCI101053

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  1 in total

1.  OXYGEN CONSUMPTION, OXYGEN DEBT AND LACTIC ACID IN CIRCULATORY FAILURE.

Authors:  J Meakins; C N Long
Journal:  J Clin Invest       Date:  1927-06       Impact factor: 14.808

  1 in total
  7 in total

1.  DYSPNOEA IN CYANOTIC CONGENITAL HEART DISEASE.

Authors:  H DAVIES; N GAZETOPOULOS
Journal:  Br Heart J       Date:  1965-01

2.  The role of anaerobic metabolism in the performance of mild muscular work. I. Relationship to oxygen consumption and cardiac output, and the effect of congestive heart failure.

Authors:  W E HUCKABEE; W E JUDSON
Journal:  J Clin Invest       Date:  1958-11       Impact factor: 14.808

3.  The role of anaerobic metabolism in the performance of mild muscular work. II. The effect of asymptomatic heart disease.

Authors:  W E HUCKABEE
Journal:  J Clin Invest       Date:  1958-11       Impact factor: 14.808

4.  Relationships of pyruvate and lactate during anaerobic metabolism. I. Effects of infusion of pyruvate or glucose and of hyperventilation.

Authors:  W E HUCKABEE
Journal:  J Clin Invest       Date:  1958-02       Impact factor: 14.808

5.  [Effect of Crataegus acids on the venous blood lactic acid in humans during and after dosed effort at an ergometer].

Authors:  G KOTTMEYER
Journal:  Klin Wochenschr       Date:  1955-09-15

6.  Arterial blood gases and acid-base balance in cyanotic congenital heart disease.

Authors:  M MORSE; D E CASSELS
Journal:  J Clin Invest       Date:  1953-09       Impact factor: 14.808

7.  The Control of Pulmonary Ventilation in Physiological Hyperpnea.

Authors:  J C Sinnott
Journal:  Can Med Assoc J       Date:  1961-03-04       Impact factor: 8.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.